1
(1) The Department of Health shall establish an Office of Medical Marijuana Use under the direction of the Deputy State Health Officer.
(2) The Office of Medical Marijuana Use may enhance access to investigational new drugs for Florida patients through approved clinical treatment plans or studies. The Office of Medical Marijuana Use may:
(a) Create a network of state universities and medical centers recognized pursuant to s. 381.925.
(b) Make any necessary application to the United States Food and Drug Administration or a pharmaceutical manufacturer to facilitate enhanced access to medical use of marijuana for Florida patients.
(c) Enter into any agreements necessary to facilitate enhanced access to medical use of marijuana for Florida patients.
(3) The department may adopt rules necessary to implement this section.
(4) The Office of Medical Marijuana Use shall administer and enforce s. 381.986.
History.—s. 4, ch. 2014-157; ss. 1, 16, ch. 2017-232.
1Note.—Section 1, ch. 2017-232, provides that “[i]t is the intent of the Legislature to implement s. 29, Article X of the State Constitution by creating a unified regulatory structure. If s. 29, Article X of the State Constitution is amended or a constitutional amendment related to cannabis or marijuana is adopted, this act shall expire 6 months after the effective date of such amendment.” If such amendment or adoption takes place, s. 385.212, as amended by s. 1, ch. 2017-232, will read:
385.212 Powers and duties of the Department of Health; Office of Compassionate Use.—
(1) The Department of Health shall establish an Office of Compassionate Use under the direction of the Deputy State Health Officer.
(2) The Office of Compassionate Use may enhance access to investigational new drugs for Florida patients through approved clinical treatment plans or studies. The Office of Compassionate Use may:
(a) Create a network of state universities and medical centers recognized pursuant to s. 381.925.
(b) Make any necessary application to the United States Food and Drug Administration or a pharmaceutical manufacturer to facilitate enhanced access to compassionate use for Florida patients.
(c) Enter into any agreements necessary to facilitate enhanced access to compassionate use for Florida patients.
(3) The department may adopt rules necessary to implement this section.